Nebulizer Devices Market Analysis | 2024-2030

Nebulizer Devices Market Analysis | 2024-2030

Nebulizer Devices Market Analysis | 2024-2030
Report code - SRHL253 Delivery - 2 Weeks
Nebulizer Devices Market Size, Share, Trends, Dynamics, Forecast, & Growth Analys See more...

Market Insights

The nebulizer devices market was estimated at USD 1.13 billion in 2023 and is likely to grow at a CAGR of 6.0% during 2024-2030 to reach USD 1.71 billion in 2030.

Nebulizer-Devices-Market-Insights

Want to know more about the market scope? Register Here

Market Dynamics

Introduction

Nebulizers are respiratory drug delivery therapeutic devices that help to transform liquid drugs into aerosols or mists and deliver them directly to the lungs. The nebulization technique is commonly used to treat respiratory diseases such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). These devices are electrically powered and rechargeable. Nebulizers are specifically used to deliver liquid medication to the breathing passage, thus reducing the bulging of the mucous membrane caused by pollutants.

COVID-19 Impact

The unprecedented outbreak of COVID-19 resulted in surging demand for mechanical ventilators, thus creating a substantial shortage of these devices in major COVID-19-affected countries.

The unmet demand for mechanical ventilators is encouraging medical professionals to shift towards other respirator devices such as nebulizers and oxygen concentrators. Thus, this is a key factor positively influencing product demand in the present period.

Market Drivers

A rise in environmental pollution and a surge in the number of smokers propel the need for nebulizer devices.

  • The rising of chronic respiratory diseases, the growing geriatric population, and increasing demand for home-based healthcare devices are some of the factors boosting the nebulizer devices market growth.
  • Also, increasing consumption of tobacco, alcohol, and ultra-processed products such as sugar-sweetened beverages is one of the prime causes behind the rising prevalence of respiratory diseases, especially in North America.
  • Furthermore, according to WHO, there were around 3.2 million deaths across the globe due to COPD.

Nebulizer-Devices-Market-Dynamics

Want to have a closer look at this market report? Click Here

Key Players

Key players operating in the nebulizer devices market are:

  • Agilent Technologies, Inc. (The U.S),
  • Allied Healthcare Products, Inc. (The U.S),
  • CareFusion Corporation (The U.S),
  • Covidien plc (Ireland),
  • GE Healthcare (The U.S),
  • GF Health Products Inc. (The U.S),
  • Omron Healthcare, Inc. (Japan),
  • PARI GmbH (Germany),
  • Koninklijke Philips N.V. (Netherlands), and
  • Briggs Healthcare (The U.S).

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Segment Analysis

Segmentations

List of Sub-Segments

Segments with High Growth Opportunity

Type Analysis

Jet, Ultrasound, Mesh

The jet segment held a considerable market share in 2023 and is likely to grow at the fastest CAGR during the forecast period.

Regional Analysis

North America, Europe, Asia-Pacific, and Rest of the World

North American market garnered the highest market share of more than 25% in 2023 and is projected to grow at a steady CAGR during the assessment period.

By Type

Based on type, the nebulizer devices market has been categorized into jet, ultrasound, and mesh.

  • Under these, the jet segment held a considerable market share in 2023 and is likely to grow at the fastest CAGR during the forecast period.
  • This is mainly attributed to the technologically advanced compact size devices and minimized drug loss, thus enhancing the effectiveness of the nebulizer devices.
  • Other factors such as portability, quick treatment, increased patient acceptance, and convenience bolster the market expansion.

Regional Trends

By region, the North American market garnered the highest market share of more than 25% in 2023 and is projected to grow at a steady CAGR during the assessment period.

This is mainly attributed to the rising respiratory disorders, well-established healthcare infrastructure, rise in customer awareness, and government initiatives such as favorable reimbursement scenario, which further accelerates the regional market growth.

Nebulizer-Devices-Market-Regional-Insights

Know which region offers the best growth opportunities. Register Here

Research Methodology

  • This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects nebulizer devices market realities and future market possibilities for the forecast period.
  • The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.
  • The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
  • This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
  • More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
  • We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis.
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
  • Market trend and forecast analysis.
  • Market segment trend and forecast.
  • Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
  • COVID-19 impact and its recovery curve
  • Attractive market segments and associated growth opportunities.
  • Emerging trends.
  • Strategic growth opportunities for the existing and new players.
  • Key success factors.

Market Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The nebulizer devices market is segmented into the following categories:

By Product Type

  • Jet
  • Ultrasound
  • Mesh

By End-Use Type

  • Hospital and clinics
  • Emergency Centers
  • Home Healthcare

By Region

  • North America (Country Analysis: the USA, Canada, and Mexico) 
  • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
  • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
  • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Nebulizer-Devices-Market-Segmentation

Click here, to learn the market segmentation details.

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to 3 players)
  • SWOT analysis of key players (up to 3 players)

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

Nebulizers are respiratory drug delivery therapeutic device that helps to transform the liquid drug into aerosols or mist and delivers it directly to the lungs. The nebulization technique is commonly used to treat respiratory diseases such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease (COPD). These devices are electrically powered and rechargeable. Nebulizers are specifically used to deliver liquid medication to breathing passage, thus reducing the bulging of the mucous membrane caused by pollutants.

The nebulizer devices market was estimated at USD 1.13 billion in 2023.

The nebulizer devices market is likely to reach USD 1.71 billion in 2030.

The nebulizer devices market is likely to grow at a CAGR of 6.0% during 2024-2030.

Agilent Technologies, Inc. (The U.S), Allied Healthcare Products, Inc. (The U.S), CareFusion Corporation (The U.S), Covidien plc (Ireland), GE Healthcare (The U.S), GF Health Products Inc. (The U.S), Omron Healthcare, Inc. (Japan), PARI GmbH (Germany), Koninklijke Philips N.V. (Netherlands) and Briggs Healthcare (The U.S) are among the top players in the market.

The North American market garnered the highest market share of more than 25% in 2023.

A rise in environmental pollution and a surge in the number of smokers, the rising of chronic respiratory diseases, the growing geriatric population, and the increasing demand for home-based healthcare devices are the factors driving the growth of the market.

Nebulizer devices companies, Hospitals, R&D organizations, Respiratory devices manufacturing companies, and Government organizations are the target audience in the market.